NCT04301765 2026-03-31
TEMEC
Seattle Institute for Biomedical and Clinical Research
Phase 2 Recruiting
Clinical Trials
28 trialsNCT06075953 2026-03-16
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
QuantumLeap Healthcare Collaborative
Phase 2 Recruiting
NCT06733350 2026-02-09
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
Roswell Park Cancer Institute
Phase 4 Suspended
NCT06084338 2025-12-31
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
VA Office of Research and Development
Phase 2 Recruiting
NCT05011383 2025-07-09
VA-BAT
VA Office of Research and Development
Phase 2 Recruiting
NCT04833426 2025-05-02
ENFORCE
Canisius-Wilhelmina Hospital
Phase 3 Recruiting
NCT01573442 2025-01-28
Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT05156606 2024-08-09
T&T
University Medical Center Groningen
Phase NA Terminated
NCT03339635 2024-07-30
Short-term Testosterone Replacement in Testicular Cancer Survivors
University Medical Center Groningen
Phase 2 Completed
NCT02873559 2024-05-29
PROGRESS
University Hospital, Gentofte, Copenhagen
Phase 2/3 Completed
NCT02995330 2024-02-13
Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Terminated
NCT01187485 2023-11-29
A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer
University of Chicago
Phase 1 Completed
NCT00587431 2023-11-07
Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT04492553 2022-11-29
Vitality
Herlev Hospital
Phase 2 Completed
NCT04424654 2022-08-03
PSMA-BAT
Hospital Sirio-Libanes
Phase 2 Completed
NCT02991209 2020-03-06
Einstein
Rigshospitalet, Denmark
Phase 2/3 Completed
NCT00805207 2018-08-01
SCOR
Washington University School of Medicine
Phase NA Completed
NCT01750398 2016-12-05
BAT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00965341 2016-09-13
Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Completed
NCT01084759 2016-05-09
A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed
NCT00586898 2016-03-25
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00853697 2015-10-30
Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT01909141 2015-10-20
Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS
Cairo University
Phase EARLY_PHASE1 Completed
NCT00515112 2014-06-11
Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer
University of Chicago
Phase 2 Terminated
NCT01697345 2014-01-24
Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy
Creighton University
Phase EARLY_PHASE1 Completed
NCT00577980 2013-04-29
Testosterone in Castration-Resistant Prostate Cancer
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT01122342 2010-05-13
Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.
University of Vermont
Phase 1/2 Suspended
NCT00497458 2009-04-09
ART2
Havah Therapeutics Pty Ltd
Phase 2 Unknown